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ABSTRACT: In this study, the effect of vitamin C on cadmium-induced toxicity was investigated. Wister rats were 
exposed to cadmium (as CdSO4.8H2O), by sub-cutaneous injection, at doses of 1.0, 2.0 and 3.0 μg/kg body 
weight, with or without vitamin C supplementation, for four weeks. Serum alkaline phosphatase activity of the 
group of rats not supplemented vitamin C (group III) significantly (p<0.05) increased, all the groups supplemented 
with vitamin C also had significantly (p<0.05) increased serum alkaline phosphatase. The bone protein level and 
serum calcium of the vitamin C untreated group of rats, significantly (p<0.05) decreased relative to control. The 
bone calcium of the vitamin C treated rats significantly (p<0.05) decreased (group IIIc from 2896.30 ± 344.64 mg 
Ca/dl to 1049 ± 101.43 mg Ca/dl) while the bone phosphate of this same group of rats, significantly (p<0.05) 
increased. For some parameters evaluated, such as serum calcium and bone protein concentration, the effects of 
cadmium on the vitamin C treated rats were less pronounced, indicating that vitamin C may be protective against 
cadmium-induced toxicity. 
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INTRODUCTION  
For non-smoking, non-occupationally exposed 
population, food, especially of vegetable origin, is the 
main source of cadmium exposure (Kierstin, 2003). It is 
estimated that 98% of the ingested cadmium comes 
from terrestrial foods, while only 1% comes from 
aquatic foods such as fish and shellfish, and 1% arises 
from cadmium in drinking water (Van Assche, 1998). 
Acute ingestion of cadmium produces severe 
gastrointestinal irritation, which is manifested as severe 
nausea and vomiting, abdominal cramps and diarrhea. 
A lethal dose of cadmium for ingestion is estimated to 
be between 350 and 8900 milligrams (Fauci et al., 
1998). The chronic effects of cadmium are dose-
dependent and also depend on the route by which the 
metal enters the body. Chronic inhalation causes 
emphysema and obstructive airways disease, and 
these occur before kidney damage is seen (Timbrell, 
1995; Fauci et al., 1998; Baldwin and Marshall, 1999). 
Long term ingestion causes kidney damage, which is 
first seen as proteinuria and ß2microglobulinuria (Fauci 
et al., 1998; Williams et al., 1999). In prolonged 
cadmium exposure, disorders of calcium metabolism 
occur, causing osteomalacia (Fauci et al., 1998; 
Williams et al., 1999). This leads to painful fractures, 
hence the name given to the chronic exposure disease 
in Japan: Itai-itai disease (literally “ouch!-ouch!” 
disease) (Fauci et al., 1998; Williams et al., 1999). 
Cadmium is also known to be carcinogenic, and studies 
have linked it with cancers of the lungs and prostate 
(Timbrell, 1995; Fauci et al., 1998; Williams et al., 
1999). 
 
Studies have shown that vitamin C supplementation 
has varied effects on induced toxicity (Netke et al., 
1997). Ascorbic acid has been found to interact with 
several elements in such a way as to render them less 
available for animals (Hill, 1980). Grosicki (2004) 
reported a decrease in the carcass cadmium burden 
and the cadmium contents in the liver, kidney, testicles 
and muscles of cadmium exposed rats (1.0-
1.2mgCd/kgb.w) given water supplemented with vitamin 
C (1.5mg/L) for 28days.  
 
Apart from accidental and occupational exposure to 
cadmium, the general population in southern Nigeria is 
facing an increasing risk of cadmium exposure. A 
comprehensive and continuous monitoring of Warri 
River (Nigeria) between 1986 and 1991, showed that 
the average level of cadmium was 0.3mg/litre (Egborge, 
1994); this far exceeds the minimum allowable level of 
cadmium in drinking water (0.005mg/litre) (WHO, 
1984). This study was designed to evaluate the 
protective effects of vitamin C in rats exposed to low 
doses of Cd, i.e. doses that are frequently encountered 
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in the natural environment, as a means of ameliorating 
its toxic effects.  
 
MATERIALS AND METHODS 
Chemicals and Reagents  
Hydrated Cadmium sulphate (CdSO4.8H2O) and other 
analytical grade chemicals used for this study were 
produced by E. Merch Darmstadt, Germany and BDH 
Chemical Limited, Poole, England. Pharmaceutical 
grade vitamin C tablets were obtained from Emzor 
Pharmaceuticals, Lagos, Nigeria. Alkaline phosphatase 
and calcium kits were products of Quimica Clinica 
Applicada SA (QCA), Spain, purchased from Equator 
Medics, Benin City, Nigeria. 
 
Experimental Animals and Management  
Forty-eight post weaned healthy albino rats (Rattus 
novergicus) of average weight 84.20g were obtained 
from the Animal Unit of Lagos University Teaching 
Hospital (LUTH), Nigeria. Treatment of the animals was 
in accordance with the Principles of Laboratory Animal 
Care (NIH Publication 85-93, revised1985). They were 
divided into eight (8) groups of six (6) rats each. All the 
rats were maintained on commercial feeds, product of 
Bendel Feeds and Flour Mill, BFFM, Ewu, Nigeria. A 
set of four groups (I, II, III, and IV) corresponding to 
control, 1.0, 2.0 and 3.0µgCd/kg body weight were 
given water, while another set of four groups (Ic, IIc, IIIc 
and IVc) corresponding to control, 1.0, 2.0 and 
3.0µgCd/kg body weight were given 5% vitamin C 
solution in place of water.  
 
Once a day, five days a week, the rats were given 
0.25ml of the appropriate cadmium solution or distilled 
water per 100g body weight by subcutaneous injection. 
Each rat was weighed weekly. At the end of the fourth 
week, the rats were anaesthetized in a chloroform 
saturated chamber and while under the influence of the 
anaesthesia, the kidneys and femur bones were 
collected. The tissues were homogenized in ice cold 
physiological saline (1:4 w/v of saline), blood was 
collected by heart puncture, allowed to clot on ice and 
then centrifuged at 5,000rpm for 5minutes. The 
supernatant of the centrifuged homogenates and the 
sera was kept frozen until analyses. 
 
One of the femur bones from each rat was ashed at 
600 oC for 12 h in a Gallenkamp muffle furnace (model 
FR614, Gallenkamp & Co., England). The ashed bones 
(dissolved in 2M HCl) were used for the determination 




Serum, kidney and bone alkaline phosphatase (ALP) 
activities were assessed using QCA alkaline 
phosphatase kits. Briefly, the method measures 
spectrophotometrically, the intensity of the pink colour 
of phenolphthalein which is obtained by the hydrolysis 
of a colourless substrate phenolphthalein 
monophosphate by ALP (Babson et al., 1966). Serum, 
kidney and bone protein levels were assayed by Biuret 
method (Gornall et al., 1949) method. Serum and bone 
calcium concentrations were measured 
spectrophotometrically at 565nm, using QCA calcium 
kits. At alkaline pH, calcium forms a coloured complex 
with O-cresolpthalein, 8-hydroxyquinolein is added to 
the reagent as a chelating agent of magnesium ions 
which can interfere with the reaction (Baginski et al., 
(1973). Serum and bone inorganic phosphate were 
measured spectrophotometrically at 625nm, according 
to the method described by Plummer (1978). In this 
method, ammonium molybdate-H2SO4 reagent reacts 
with inorganic phosphate to form complexes which is 
reduced to give a blue colour that can be read 
spectrophotometrically by adding 0.2% ascorbic acid. 
 
Statistical Analyses 
Values are expressed as means of 5 or 6 
determinations ± SEM. The results obtained for the 
vitamin C treated and untreated groups were analyzed 
separately (within the column) by the Independent 
Samples T-test, each group was compared to its 
respective control on SPSS 11.0, SPSS Inc., Chicago, 
Illinois, USA.. A p<0.05 was considered statistically 
significant. 
 
RESULTS AND DISCUSSION 
Table 1 shows a general steady increase in body 
weight gain in the vitamin C untreated and treated 
groups of rats, however, while the final body weight of 
all tests groups of the vitamin C untreated rats 
decreased compared to control, only Group IIc of the 
vitamin C treated groups showed a significant (p<0.05) 
decrease in final body weight compared to control. 
Group IVc actually recorded a significantly (p<0.05) 
higher final body weight compared to control. Asagba et 
al. (2006) reported that rats given 3 mg Cd/ kg body 
weight (as CdCl2) for 4 weeks, had lower final body 
weight (p<0.05) compared to control. Ribas et al. 
(2004) also reported that the pups of female rats 
supplied with drinking water containing 300 mg/l of 
CdCl2 during lactation, showed significantly lower 
(p<0.01) body weight than control pups. Grosicki and 
Kowalski (2002), reported that rats exposed for 4 weeks 
to CdCl2 (labeled with cadmium-109) at 10 mg/ kg diet, 
showed a steady increase in average body weight gain 
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throughout the experiment, however the final body 
weight of the rats exposed to Cd was markedly lower in 
comparison to the control rats. This observation 
correlates with the results obtained for the vitamin C 
untreated rats in this study.  
 
Table 2 shows the general decreases observed in the 
bone- and kidney-body weight ratios for both set of rats, 
however, group IIc bone-body weight ratio was similar 
to its corresponding control. The kidney-body weight 
ratio of this same group was significantly (p<0.05) 
higher than its control (Ic).  
 
Since chemical toxicity can be assessed by changes in 
the body weight and organ-body weight ratio (Timbrell, 
1991), the significant alterations of these parameters in 
the Cd-treated rats, especially the vitamin C untreated 
rats implies Cd toxicity. The fact that only group IIc of 
the vitamin C treated rats showed a significant (p<0.05) 
decrease in final body weight, while all the vitamin C 
untreated rats had significantly (p<0.05) decreased final 
body weights compared to their corresponding control, 
implies that vitamin C had a protective effect against 
the Cd-induced body weight reduction. 
 
Since the kidney and bone are implicated in non-acute 
cadmium exposure, the serum, kidney and bone ALP 
were determined in this study. The bile canaliculli of the 
liver, osteoblasts in the bone, proximal tubules in the 
kidney and mucosal cells of the small intestine, are rich 
sources of alkaline phosphatase (Verley, 1967). 
Damage to any of these organs or tissues would lead to 
elevated activity of the ALP isoform in the serum (Lin 
and Wang, 1986; Ngaha et al., 1989). 
 
 Table 1: Body Weight of rats administered doses of cadmium  
Group  Body Weight (g) 
Week 0 (Initial) Week 1 Week 2 Week 3 Week 4 (Final) 
I 78.60 a ±5.036 80.10a ±5.675 90.70a ±5.682   94.80a ±5.472 108.10a ±6.346 
II 85.67 b ±5.137 81.50a ±5.130 90.83a ±5.320 101.67b ±5.664 102.25b ±5.470 
III 69.42b±3.348 66.25b ±3.007 82.50b ±3.601             96.67a ±3.712 103.67b ±3.803 
IV 75.00 a ±4.645 83.75b ±4.727 87.25a ±4.765   93.75a ±5.028 102.17b ±5.143 
Ic 86.12 a*±6.360 94.7 a*±6.878 99.39a*±7.328 110.00a*±7.292 111.88a*±7.920 
IIc 81.21 a*±6.084 72.4 b*±5.597 85.30b*±5.98   89.20b*±5.245   88.10b*±4.488 
IIIc 104.50b*±8.24 95.10a*±8.141 102.60a*±8.95 115.30b*±10.14 124.80b*±10.99 
IVc 93.10b*±5.382 96.10a*±4.831 99.30a*±5.408 102.80a*±5.126 108.80a*±4.596 
Values are mean of five or six determinations ± standard error of the mean. Values carrying b and b* are significantly (p<0.05) different from 
control (a and a*). 
Table 2: Organ- Body Weight Ratio of rats administered doses of cadmium.
Group  Organ-Body Weight Ratio (X 10-3) 
Bone Kidney 
I 7.5a±0.42 8.8a ±0.28 
II 7.2b±0.23 8.1b ±0.30 
III 6.6b ±0.05 8.4b ±0,27 
IV 7.9b ±0.30 8.1b ±0.25 
Ic 8.8a*±0.78 8.1a*±0.62 
IIc 8.7 a*±0.32 8.7b*±0.10 
IIIc 7.7b*±0.30 7.3b*±0.26 
IVc 7.0b*±0.14 7.3b*±0.28 
Values are mean of five or six determinations ± standard error of the mean. Values carrying b and b* are significantly (p<0.05) different from 
control (a and a*). 
I = Rats fed with 0 μgCd/kg Body weight             Ic = Rats fed with 0 μgCd/kg Body weight + 5% vitamin C solution 
II = Rats fed with 1.0 μgCd/kg Body weight             IIc = Rats fed with 1.0 μgCd/kg Body weight + 5% vitamin C solution 
III = Rats fed with 2.0 μgCd/kg Body weight             IIIc = Rats fed with 2.0 μgCd/kg Body weight + 5% vitamin C solution 
IV = Rats fed with 3.0 μgCd/kg Body weight    IVc = Rats fed with 3.0 μgCd/kg Body weight + 5% vitamin C solution 
 
Table 3 shows significant (p<0.05) decreases observed 
in tissue ALP of almost all the groups of the vitamin C 
untreated and treated rats. Axelsson and Piscator 
(1966), reported a reduction in the ALP activity of renal 
cortex in rabbits given 0.5mgCd/kg body weight. 
Saillenfait et al. (2006) also reported that pups from 
pregnant rats intraperitoneally injected with CdCl2 at 2.5 
mg/kg body weight for up to 14 days of gestation, 
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exhibited significant decreases in renal ALP activity. 
The significantly high serum ALP (Table 3) observed in 
this study could be as a result of the leakage of this 
enzyme from damaged tissues, rich in ALP, into the 
blood stream. This is particularly evident in the vitamin 
C treated groups where both bone and kidney ALP 
were significantly (p<0.05) decreased while the serum 
enzyme significantly (p<0.05) increased compared to 
control (Ic). Itokawa et al. (1978) observed an increase 
in the activity of serum ALP coincident with changes in 
the skeleton after 120days of oral exposure to 50ppm 
cadmium. Akesson et al. (2006), using a population 
based women health survey in Southern Sweden to 
investigate the association between low-level cadmium 
exposure and osteoporosis, reported that urinary 
cadmium displayed a near-significant (p<0.06) 
association with serum bone-alkaline phosphatase 
(bALP). Since the kidney and bone, are established 
target organs of cadmium toxicity (Ahn and Park, 1995; 
Kido et al., 1995); in addition to the decreased tissue 
ALP observed in this study, it is plausible to conclude 
that the increase in serum ALP is a reflection of the 
decreased bone and kidney ALP.  
 
Serum total protein level is a rough measure of protein 
status but reflects major functional changes in kidney 
and liver functions (Pachathundikandi and Verghese, 
2006).  
 
Table 3: Serum, kidney and bone alkaline phosphatase of rats administered doses of cadmium. 
Group Alkaline Phosphatase U/L 
 Bone Kidney Serum 
I 215.16a ±2.56 466.32a ±14.69 99.51a ±2.22 
II 193.78b ±15.14 411.28b ±12.26 94.62a ±2.63 
III 192.51b ±13.48 467.19a ±8.51 146.09b ±6.11 
IV 182.63b ±12.77 435.01b ±14.71 118.73a ±2.40 
Ic 286.60a*±15.83 494.15a*±15.30 74.26a*±10.15 
IIc 195.81b*±10.21 436.84b*±16.49 123.22b*±3.10 
IIIc 203.80b*±12.55 448.67b*±5.10 123.22b*±3.44 
IVc 240.57b*±16.77 478.27b*±12.07 124.17b*±2.88 
Values are mean of five or six determinations ± standard error of the mean. Values carrying b and b* are significantly (p<0.05) different from 
control (a and a*). 
I = Rats fed with 0 μgCd/kg Body weight            Ic = Rats fed with 0 μgCd/kg Body weight + 5% vitamin C solution 
II = Rats fed with 1.0 μgCd/kg Body weight            IIc = Rats fed with 1.0 μgCd/kg Body weight + 5% vitamin C solution 
III = Rats fed with 2.0 μgCd/kg Body weight            IIIc = Rats fed with 2.0 μgCd/kg Body weight + 5% vitamin C solution 
IV = Rats fed with 3.0 μgCd/kg Body weight          IVc = Rats fed with 3.0 μgCd/kg Body weight + 5% vitamin C solution 
Table 4 shows the serum, kidney and bone protein 
levels. Low doses of cadmium administration for 4 
weeks appears to have a general lowering effect on the 
bone, kidney and serum protein levels of the vitamin C 
treated groups. Also, the significant reduction in the 
bone protein level of group IV of the Vitamin C 
untreated rats, show that cadmium interferes with bone 
protein levels. The reductions observed in the bone, 
kidney, and serum protein levels of all test groups of the 
vitamin C treated rats are puzzling, however, since 
statistical analysis show that vitamin C alone 
significantly (p<0.05) increased the bone, kidney and 
serum protein levels of group Ic (Table 6), the 
reductions observed can be attributed to cadmium-
induced toxicity. Proteinuria due to kidney impairment in 
cadmium toxicity may be the cause of protein loss in 
the test groups since inhibitory role of cadmium in 
protein synthesis has not been established. 
 
The reduction in serum calcium in the vitamin C 
untreated groups is a reflection of the effect of cadmium 
on calcium metabolism (Table 5). The decreased Ca2+ 
absorption and negative calcium balance in cadmium 
exposed rats could result from the inhibitory effect of 
cadmium on the activation of vitamin D in renal cortical 
cells (Feldman and Cousins, 1973). Nogawa et al. 
(1987) reported that serum 1,25-
dihydroxylcholecalciferol levels were lower in Itai-Itai 
disease patients and cadmium exposed subjects with 
renal damage. A reduction in serum calcium level 
(hypocalcaemia) stimulates the release of calcium from 
bone, this correlates well with the reduced bone 
calcium observed in the test groups of the vitamin C 
untreated and vitamin C treated rats. Itokawa et al. 
(1978) reported that simultaneous administration of 
cadmium with a low-protein, low-calcium diet led to a 
decrease in calcium and zinc content of the bone.  
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Cadmium can affect calcium, phosphorus and bone 
metabolism (Mukunoki and Fujimoto, 1996). Reductions 
in serum 1, 25-dihydroxycholecalciferol in cadmium-
exposed subjects, are closely related to serum 
concentrations of parathyroid hormone (PTH), β2-
microglobulin and the percentage tubular reabsorption 
of phosphate (Nogawa et al., 1987), suggesting that 
cadmium-induced bone effects may also be due to 
disturbances in vitamin D and PTH metabolism 
(Kjellstrom, 1992). Phosphorus is important for the 
modulation of calcium mobilization from the bone and 
the regulation of plasma calcium (Felsenfeld and 
Rodriguez, 1999). Increase in serum calcium is 
associated with decrease in serum phosphorus and 
increased urinary phosphorus excretion and vice versa 
(Felsenfeld and Rodriguez, 1999). 
 
The results obtained for serum calcium and phosphate 
in this study (Tables 5) do not sufficiently reflect the 
reciprocal relationship between calcium and 
phosphorus, however, group IVc, of the vitamin C 
treated rats, shows an increased calcium level while its 
phosphate level is decreased. The results for bone 
calcium and phosphate levels of the vitamin C treated 
rats, correlate better with the reciprocal relationship 
between calcium and phosphorus. 
 
Table 4: Serum, kidney and bone protein levels of rats administered doses of cadmium. 
Group Protein Levels mg/ml 
Bone Kidney Serum 
I 5.38a ±0.41 12.13a ±0.74 47.80a ±1.04 
II 6.00b ±0,33 14.50b ±0.67 52.50b ±0.48 
III 6.00b ±0.42 12.50a ±0.44 48.90a ±1.26 
IV 2.70b ±0.27 11.50b ±0.54 47.75a ±0.95 
Іc 6.67 a*±0.52 15.00a*±0.90 52.75a*±2.31 
IIc 4.80b*±0.51 8.88b*±0.71 42.80b*±1.15 
IIIc 5.63b*±0.28 9.10b*±0.49 49.80b*±0.55 
ІVc 6.88a*±0.43 11.25b*±1.32 46.75b*±1.48 
Values are mean of five or six determinations ± standard error of the mean. Values carrying b and b* are significantly (p<0.05) different from 
control (a and a*). 
 
Table 5: Calcium and Phosphate Levels in Serum and Bone of Rats Administered Doses of Cadmium 
Group  Calcium mg Ca/dl Phosphate Levels μg/ml 
 Bone Serum Bone Serum 
I 1641.98a±119.19 12.23a ±0.54 1397.50a±37.68 253.75a±7.37 
II 1323.46b ±94.25 11.16b ±0.18 1310.00b ±19.68 196.67b ±0.96 
III 1033.33b ±129.00 8.24b ±0.49 1362.50a ±33.38 188.75b ±9.96 
IV 1739.46b ±28.21 8.48b ±0.10 1479.17b ±20.98 240.00a ±5.93 
Іc 2896.30a*±344.64 10.10a*±0.14 1200.00a*±15.10 318.33a*±26.94 
IIc 1017.28b*±40.65 8.46b*±0.20 1295.00b*±30.57 70.00b*±2.83 
IIIc 1049.99b*±101.43 8.99b*±0.38 1400.00b*±30.77 176.25b*±12.15 
IVc 1370.37b*±108.56 12.2b*0±0.20 1347.50b*±19.24 211.67b*±14.84 
Values are mean of five or six determinations ± standard error of the mean. Values carrying b and b* are significantly (p<0.05) different from 
control (a and a*). 
 
I = Rats fed with 0 μgCd/kg Body weight            Ic = Rats fed with 0 μgCd/kg Body weight + 5% vitamin C solution 
II = Rats fed with 1.0 μgCd/kg Body weight            IIc = Rats fed with 1.0 μgCd/kg Body weight + 5% vitamin C solution 
III = Rats fed with 2.0 μgCd/kg Body weight            IIIc = Rats fed with 2.0 μgCd/kg Body weight + 5% vitamin C solution 
IV = Rats fed with 3.0 μgCd/kg Body weight          IVc = Rats fed with 3.0 μgCd/kg Body weight + 5% vitamin C solution. 
 
Analysis of groups I and Ic, show that vitamin C alone 
positively influenced most of the parameters evaluated 
(Table 6). For some of the parameters evaluated, 
recognizable differences were observed between the 
vitamin C untreated and the vitamin C treated groups of 
rats, These include: The final body weights of groups 
IIIc and IVc of the vitamin C treated rats did not 
decrease relative to control, while all the groups of the 
vitamin C untreated rats decreased compared to their 
control. The bone protein concentration of group IV of 
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the vitamin C untreated groups of rats show a 
significant (p<0.05) decrease compared to its control, 
while there was no significant difference in group IVc of 
the vitamin C treated groups, compared to its control. A 
significant (p<0.05) decrease in serum calcium was 
observed in all the vitamin C untreated groups, group 
IVc of the vitamin C treated groups, show a significant 
increase compared to its control.  
Cadmium may also exert its toxicity via oxidative 
damage. Valko et al. (2005) reported that the primary 
route for cadmium toxicity is depletion of glutathione 
and binding to sulfhydryl groups of protein. It is 
therefore not surprising that vitamin C, an antioxidant, 
would play a protective role against cadmium toxicity. 
 
 
Table 6: Effect of Vitamin C on all Parameters Evaluated 
Parameter Group I Group Ic 
Final Body Weight (g) 108.10 ± 6.346 a 111.88 ± 7.920 a 
Bone-Body Weight Ratio 7.5 ± 0.42 a 8.8 ± 0.78 b 
Kidney-Body Weight Ratio 8.8 ± 0.28 a 8.1 ± 0.62 b 
Bone ALP U/L 215.16 ± 2.56 a 286.60 ± 15.83 b 
Kidney ALP U/L 466.32 ±14.69 a 494.15 ± 15.30 b 
Serum ALP U/L 99.51 ± 2.22 a 74.26 ± 10.15 b 
Bone Protein Level mg/ml 5.38 ± 0.41 a 6.67 ± 0.52 b 
Kidney Protein Level mg/ml 12.13 ± 0.74 a 15.00 ± 0.90 b 
Serum Protein Level mg/ml 47.80 ± 1.04 a 52.75 ± 2.31 b 
Bone Calcium Level mgCa/dl 1641.98 ±119.19 a 2896.30 ± 344.64 b 
Serum Calcium Level mgCa/dl 12.23 ± 0.54 a 10.10 ± 0.14 a 
Bone Phosphate level μg/ml 1397.50 ± 37.68 a 1200.00 ± 15.10 b 
Serum Phosphate level μg/ml 253.75 ± 7.37 a 318.33 ± 26.94 b 
Values are mean of five or six determinations ± standard error of the mean. Values carrying b and b* are significantly (p<0.05) different from 
control (a and a*). 
I = Rats fed with 0 μgCd/kg Body weight            Ic = Rats fed with 0 μgCd/kg Body weight + 5% vitamin C solution 
 
CONCLUSION 
The findings from this study have shown that 
subcutaneous administration of low doses of cadmium 
to rats either with or without vitamin C supplementation 
caused an increase in serum ALP and bone phosphate. 
It also caused a decrease in bone protein 
concentration, serum calcium and bone calcium, 
indicating that under the conditions of this study, the 
bone is the major target of cadmium toxicity. Vitamin C 
may play a protective role against cadmium toxicity and 
hence vitamin C can be used to ameliorate the toxic 
effect of low doses of cadmium. 
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